After February market crash, ProQR will lay off 30% of its workforce and try pushing eye...

[cafead]

via A pivotal trial flop in February caused ProQR to lose nearly two-thirds of its stock value and that means the transatlantic company will officially join the dozens of biotechs and pharmas to lay off employees in the past few months.

article source